Stock screenerAll disclosures →
EDGAR →
SER
Conviction 18HealthcareScan · Fri, Jun 26, 2026SER$1.86+2.20%
ResistanceSupportVol 14Insider buy2
Vol MA14 170.12K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price1.86
Change+2.20%
Gap+3.02%
Rel volume0.85×
Avg volume141.5K
Avg $ vol263.75K
SMA 201.87
SMA 501.84
SMA 2002.90
Price vs 50+0.96%
Price vs 200-35.95%
MA stackmixed
50/200 cross—
Supertrendup · 1.52
RSI (14)50
MACD hist-0.01
MACD crossbear · 1d
Stoch %K / %D32 / 28
ADX (14)13
+DI / −DI16 / 18
RSI divergence—
MACD divergence—
ATR %+9.62%
ADR %9.01%
52w high6.17
52w low1.28
From 52w high-69.85%
Above 52w low+45.31%
New 52w highNo
SqueezeOn · 11d
Bollinger width18.99%
%B0.48
Donchian pos33.33%
Donchian high2.18
Donchian low1.70
AVWAP (52w high)2.79
vs AVWAP high-33.35%
AVWAP (52w low)2.43
vs AVWAP low-23.60%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d0.85×
Avg vol (14d)170.12K
Avg vol (20d)141.5K
Avg $ vol (20d)263.75K
Market cap—
RS 3m (vs SPY)-51.73%
RS 6m (vs SPY)-38.54%
RS line new highNo
Trend template2/8
Technical rank23.4
1 week-11.43%
1 month+3.33%
3 months-28.74%
6 months-26.19%
1 year-68.58%
YTD-10.49%
P/E-1.44
P/B-745.82
P/S212.27
P/FCF-1.53
EPS-1.91
Div yield—
ROE—
ROA-70.27%
Debt/Eq—
Current4.18
EV/EBITDA-0.59
Gross margin78.46%
Net margin—
Rev growth132.14%
EPS growth-72.17%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value14.22M
Revenue0
Net income-6.9M
Gross profit34K
Free cash flow-18.01M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out15M
Employees16
ListedWed, Mar 27, 2024
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank23.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.11
Support1.50
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SER
No recent disclosed trades by Congress in SER. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SER · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bailey Gregory Director · Common Stock · 2026-06-17 | Convert | 1.77M | $4.0M | 2026-06-17 | 2026-06-22 |
Bailey Gregory Director · Common Stock · 2026-06-17 | Convert | 6.67M | $15M | 2026-06-17 | 2026-06-22 |
Marshall Richard Peter Director · Stock Option (right to buy) · 2026-06-17 | Grant | 15.25K | — | 2026-06-17 | 2026-06-22 |
Venkatesan Jay Director · Series A Convertible Preferred Stock · 2026-06-17 | Convert | 96.53K | $217K | 2026-06-17 | 2026-06-22 |
Bailey Gregory Director · Stock Option (right to buy) · 2026-06-17 | Grant | 15.25K | — | 2026-06-17 | 2026-06-22 |
Bailey Gregory Director · Redeemable Warrants · 2026-06-17 | Grant | 3.33M | — | 2026-06-17 | 2026-06-22 |
Venkatesan Jay Director · Common Stock · 2026-06-17 | Convert | 224.15K | $504K | 2026-06-17 | 2026-06-22 |
Venkatesan Jay Director · Stock Option (right to buy) · 2026-06-17 | Grant | 15.25K | — | 2026-06-17 | 2026-06-22 |
Bailey Gregory Director · Series A Convertible Preferred Stock · 2026-06-17 | Convert | 762.55K | $1.7M | 2026-06-17 | 2026-06-22 |
Brannan Stephen K. Director · Stock Option (right to buy) · 2026-06-17 | Grant | 15.25K | — | 2026-06-17 | 2026-06-22 |
SEC filings
EDGAR filings in SER · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.